- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02152722
Breath Test for Biomarkers in Humans Receiving Total Body Irradiation
The effect of radiation on normal tissue varies widely between individuals. Consequently, a test to measure tissue response to radiation could be clinically useful by permitting more accurate titration of dosage in patients undergoing radiotherapy. Also, in view of emerging concerns about possible nuclear terrorism a test for exposure to radiation might also be useful in evaluating victims of a "dirty bomb" explosion. A number of different techniques have been previously reported in epidemiological studies for the estimation of prior radiation exposure. This study explores one approach to estimating radiation exposure by measurement of increased oxidative stress which can be detected by a breath test.
In this study subjects undergoing significant exposure to therapeutic radiation will provide breath samples for analysis in a central laboratory. The hypothesis of the study is that the analysis of these samples will lead to the identification of a set of markers of radiation exposure.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Recruiting
- Emory University
-
Contact:
- Mohammad Khan, M.D.
-
Principal Investigator:
- Mohammad Khan, M.D.
-
-
New Jersey
-
Hackensack, New Jersey, United States, 07601
- Recruiting
- Hackensack University Medical Center
-
Principal Investigator:
- Scott Rowly, M.D.
-
-
New York
-
New York, New York, United States, 10065
- Recruiting
- Memorial Sloan Kettering Cancer Center
-
Principal Investigator:
- Chris Barker, M.D.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 18 years or older
- Subject is willing and able to cooperate with study and give signed informed consent to participate
- Subject has been diagnosed with a condition that requires treatment with a TBI protocol of daily irradiation for one to five days
- Actively smoking subjects, as well as never smokers and former smokers are eligible for the study so long as a complete smoking consumption history can be recorded
- Subject will be available for follow-up breath tests following each session of TBI. Subjects receiving only one day of TBI will be available for a follow-up 24-36 hours following TBI
- Subject is an in-patient at the hospital
Exclusion Criteria:
1. Subject has had chemotherapy within preceding 21 days
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Total Body Irradiation Subjects
Subjects undergoing total body irradiation prior to chemotherapy.
It is expected that all of these subjects will be receiving ablative radiation prior to bone marrow transplant.
Breath will be collected before and after the first radiation exposure on each day of total body irradiation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Radiation volatile organic compound (VOC) score
Time Frame: Each day of radiation exposure at time points between 1 day and 7 days post exposure.
|
An algorithm for scoring the radiation exposure based on analysis of breath samples will be developed and applied to each breath sample collected.
The hypothesis is that the scores will indicate radiation exposure, specifically exposure to more than 2 Gray at time points between 1 day and 7 days post exposure.
|
Each day of radiation exposure at time points between 1 day and 7 days post exposure.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael Phillips, M.D., Menssana Research, Inc.
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MR 2012 TBI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Radiation Injury
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityNot yet recruitingChronic Radiation Injury
-
Affiliated Hospital to Academy of Military Medical...UnknownRadiation Injuries, ExperimentalChina
-
Institute of Oncology LjubljanaCompletedRadiation Necrosis | Radiation Injury | Radiation-Induced ComplicationsSlovenia
-
Liverpool Heart and Chest Hospital NHS Foundation...Rampart Health, L.L.C.RecruitingRadiation Injuries | Radiation Exposure | Radiation Exposure to Operator | Radiation SafetyUnited Kingdom
-
Zhejiang Cancer HospitalNot yet recruitingChronic Radiation Induced Intestinal Injury | Chronic Radiation EnteritisChina
-
SG Devices LLCNational Institutes of Health (NIH); University of MinnesotaNot yet recruiting
-
Ospedale Sandro Pertini, RomaCompleted
-
National Taiwan University HospitalWithdrawn
-
Instituto de Cardiologia do Rio Grande do SulCompletedRadiation Injury | Exposure to Ionizing Radiation | Occupational Exposure to RadiationBrazil
-
Rambam Health Care CampusCompletedRadiation InjuriesIsrael